RankAlpha logo
Back to Rankings

NHC

National HealthCareB
NYSE American / Health Care Equipment & Services
Last Price
At close
2026-08-03
View Chart

AI scenario view

RankAlpha Sentiment CodexPost-earnings T+1
B+
Bull case
20%
Probability
Target price
$255.00
+14.5% vs current
Most likely
B
Base case
55%
Probability
Target price
$229.00
+2.8% vs current
B-
Bear case
25%
Probability
Target price
$195.00
-12.5% vs current

AI sentiment snapshot

Latest data as of 2026-08-03
Recent news sentiment (30D)
+28.0
Positive
Company
-
Unavailable
Macro
-
Unavailable
Pulse
+28.0
Positive
Sentiment proxy
+49.3
Score

AI commentary

News tone is mixed-positive from Q1 earnings, the dividend increase, and acquisition completion, but the T+1 earnings-specific evidence gap is material. Social coverage, analyst targets, revisions, options skew, short interest, and employee-score data are unavailable or insufficient; missing reaction data is not positive evidence.

RankAlpha Sentiment Codex - 2026-08-03
Open post-earnings memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-11-01eventQ2 earnings confirmation remains the key near-term checkpointMedium impact

The queued T+1 event references 2026-07-31 Q2 earnings, but the packet and bounded source check did not confirm a Q2 company release, SEC 8-K, transcript, consensus comparison, guidance change, or analyst revision. Treat as a two-way monitoring event, not a confirmed beat or miss.

2026-11-01eventLarge acquisition creates integration and financing inflectionMedium impact

NHC disclosed a $560 million cash purchase price for the transaction, funded through borrowings and cash, creating a material integration, leverage, and earnings-contribution checkpoint. [#8-K-2026-07-01](https://www.sec.gov/Archives/edgar/data/1047335/000143774926022306/nhc20260630_8k.htm)

2026-11-01catalystRecent insider selling may create a near-term overhangMedium impact

Several directors and officers reported open-market sales in May and June, including a director sale of 5,937 shares on June 22. Insider activity is a sentiment signal only and is not evidence of operating deterioration. [#SEC-FORM4-2026-06-23](https://www.sec.gov/Archives/edgar/data/1047335/000143774926021438/rdgdoc.xml)

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-08-03 • Updated nightlySource: Internal modelMethodology